tradmap

RDY Dr Reddys Laboratories Ltd

$14.31 +1.31%

Data as of close

Healthcare · Pharmaceutical Preparations

Dr Reddys Laboratories Ltd (RDY) is a healthcare company in the Pharmaceutical Preparations industry. Shares last traded at $14.31, 10.2% below their 52-week high. Over the past year the stock is up 7.6%.

Market Cap
—
Shares Out
—
EPS (TTM) (per ord. share)
—
P/E (TTM)*
—
P/S Ratio
—
P/B Ratio
—
Dividend / ord. share
—
Dividend Yield
—
52-Week High
$15.94
52-Week Low
$11.01
Volume (venue)
266,967
Avg Vol (3m, venue)
245,693.476

* P/E (TTM) = market cap ÷ net income over the trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year — the same basis as the peer table and the screener, so it can differ from price ÷ EPS.

Dr Reddys Laboratories Ltd reports in INR: EPS, dividends and financials are shown in INR as filed, per ordinary share. There is no share count on file for the US listing (a depositary receipt prices at a ratio we do not source), so there is no market cap and no price ratio.

Performance

1W
+4.18%
1M
+16.10%
3M
+17.82%
6M
+7.96%
YTD
+1.96%
1Y
+7.63%

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)
76.94
SMA (50)
$12.62
SMA (200)
$13.23
Price vs SMA50
+13.42%
Price vs SMA200
+8.22%
ATR (14)
$0.53

Full technical analysis (26 indicators, D/W/M) →

Pharmaceutical Preparations peers

RDY vs 14 industry peers (Pharmaceutical Preparations), by market cap. Data as of close

1–14 of 14
LLYLilly (Eli)$1.33T48.0715.3331.9%-0.12%
JNJJohnson & Johnson$640.8B39.816.4516.2%-1.76%
ONCBeone Medicines Ltd.$524.6B800.0585.5910.7%-1.72%
ABBVAbbVie$503.8B48.717.6315.7%-1.30%
MRKMerck$356.9B112.495.364.8%-2.57%
ABTAbbott Laboratories$190.6B30.374.2213.9%-0.78%
PFEPfizer$171.2B42.462.696.3%-2.18%
VRTXVertex Pharmaceuticals$134.7B33.8710.4030.7%-6.81%
BMYBristol Myers Squibb$126.1B13.652.5218.5%-2.09%
REGNRegeneron Pharmaceuticals$100.7B20.915.9628.5%+1.30%
TEVATeva Pharmaceutical Industries Ltd$48.9B96.622.842.9%+3.00%
ZTSZoetis$34.3B13.113.6027.5%-0.18%
RPRXRoyalty Pharma Plc$29.5B36.2511.6532.1%-0.26%
ROIVRoivant Sciences Ltd.$26.0B—3458.17—+0.47%

Source: SEC EDGAR (fundamentals/EPS/dividends, reported in INR) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.